Compositions of gastric acid-resistant microspheres containing buffered bile acids
June 19, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References Re30910 3004893 Preparation of enteric coated digestive enzyme compositions Pharmaceutical composition of prolonged action containing bile acids Gallstone dissolution compositions and method Process for the production of pancreatin pellets Pharmaceutical compositions containing insulin Cylindrical microtablets Carboxylic acid compositions Use of taurocholic acid and its salts as enhancers for calcitonin containing pharmaceutical compositions Patent #: 5149537 InventorAssigneeApplicationNo. 901749 filed on 06/19/1992US Classes:424/490, Coated (e.g., microcapsules)264/7, Coated particles264/13, By extrusion spraying or gravity fall through orifice264/15, SPHEROIDIZING OR ROUNDING OF SOLID PARTICLES424/456, Gelatin424/458, Containing discrete coated particles pellets, granules, or beads424/461, Containing polysaccharide (e.g., cellulose sugars, etc.)424/462, Containing solid synthetic polymers424/474, Coated pills or tablets424/480, Cellulose or derivative424/482, Containing solid synthetic polymers424/494, Cellulose derivatives424/495, Ethyl cellulose424/497, Containing solid synthetic polymers424/715, Carbonate424/717, Bicarbonate514/171, With additional active ingredient514/867, DIARRHEA514/877, GALLSTONE514/893LIVER DISORDERExaminersPrimary: Webman, Edward J.Foreign Patent References
International ClassesA61K 009/54A61K 009/58 A61K 009/62 A61K 009/16 AbstractDisclosed are gastric acid-resistant polymer-coated buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, prevention of colon cancer following cholecystectomy, cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.Field of SearchContaining solid synthetic polymersCellulose derivatives Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof Containing polysaccharide (e.g., cellulose sugars, etc.) Containing solid synthetic polymers Discrete particles in supporting matrix Where particles are granulated Cellulose or derivative Containing solid synthetic polymers Carbonate Bicarbonate ANTACID, ORAL CIRRHOSIS DIARRHEA LIVER DISORDER GALLSTONE | |
